DB-Retard en es it fr

DB-Retard Brand names, DB-Retard Analogs

DB-Retard Brand Names Mixture

  • No information avaliable

DB-Retard Chemical_Formula


DB-Retard RX_link

No information avaliable

DB-Retard fda sheet

DB-Retard msds (material safety sheet)

DB-Retard Synthesis Reference

Shapiro, Freedman, U.S. pats. 2,961,377, 3,057,780 (1960, 1962 both to U.S.V.)

DB-Retard Molecular Weight

205.26 g/mol

DB-Retard Melting Point

175-178 oC

DB-Retard H2O Solubility

210 mg/mL

DB-Retard State


DB-Retard LogP


DB-Retard Dosage Forms

No information avaliable

DB-Retard Indication

For the reatment of type II diabetes mellitus.

DB-Retard Pharmacology

Used to treat diabetes, phenformin is a biguanide (contains 2 guanidino groups) hypoglycemic agent with actions and uses similar to those of metformin (Glucophage). Both drugs work by (1) decreasing the absorption of glucose by the intestines, (2) decreasing the production of glucose in the liver, and by (3) increasing the body's ability to use insulin more effectively. More specifically, phenformin improves glycemic control by improving insulin sensitivity. Phenformin is generally considered to be associated with an unacceptably high incidence of actic acidosis. In general biguanides should be used only in stable type II diabetics who are free of liver, kidney and cardiovascular problems and who cannot be controlled with diet.

DB-Retard Absorption

No information avaliable

DB-Retard side effects and Toxicity

No information avaliable

DB-Retard Patient Information

No information avaliable

DB-Retard Organisms Affected

Humans and other mammals